Latin American Fellow 2023-24
Visiting Fellow 2023-24
Agustina Rodríguez Romero (January - March 2024)
Agustina Rodríguez Romero is an Argentine scholar and researcher at the Centro de Investigaciones sobre Arte, Materia y Cultura, IIAC-Universidad Nacional de Tres de Febrero and CONICET, Argentina. She is an Art History Professor at the Universidad Nacional de Buenos Aires. Her work concerns Spanish colonial art, the circulation of prints and paintings in the Early Modern World and the eschatological and Old Testament iconographies. Her recent research addresses the study of the visual and pastoral strategies in the Viceroyalty of Peru at the end of the 17th century.
She co-edited with Gabriela Siracusano the book Materia Americana, the body of Spanish American Images (16th to mid-19th centuries), which received two Honorable Mentions, from the Arvey Foundation Book Award, Association for Latin American Art, and from Eleanor Tufts Award, American Society for Hispanic Art Historical Studies.
Agustina has been a fellow of the Getty Foundation’s “Amerique Latine” program (France), of the Hermes program of the Fondation Maison des Sciences de l’Homme (France), of the Asociación Universitaria Iberoamericana de Postgrado (Spain), and visiting professor at the Universidad de Sevilla (Spain).
Everaldo Lamprea Montealegre (October - November 2023)
Everaldo Lamprea is a Colombian scholar who has researched and written extensively on the right to health and access to healthcare in Latin America and the global south. He holds a doctoral degree from Stanford University. Previously, he was a research fellow in residence at Harvard's human rights program. Currently, he is a professor at Universidad Nacional de Colombia in Bogotá. His most recent book, Local Maladies, Global Remedies: Reclaiming the Right to Health in Latin America (Edward Elgar Pub, 2022) summarizes his research agenda during the past decade. In Local Maladies, Global Remedies, he is specially interested in studying what has been called "pharmaceuticalization"--i.e. the negative impact of the Big Pharma Industry on access to health care, public health and the right to health in Latin America.